Guery, Benoit <br/><br/>
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial.  [electronic resource] 

 -  The Lancet. Infectious diseases  03 2018 
 - 296-307 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Clinical Trial, Phase IV; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-4457 
<br/><br/><label>Standard No.: </label>10.1016/S1473-3099(17)30751-X  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Clostridioides difficile<br/>Enterocolitis, Pseudomembranous--drug therapy<br/>Female<br/>Fidaxomicin--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Vancomycin--therapeutic use